As of 2025-05-18, the Intrinsic Value of Reviv3 Procare Co (RVIV) is 10.20 USD. This RVIV valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 12.76 USD, the upside of Reviv3 Procare Co is -20.00%.
The range of the Intrinsic Value is 8.48 - 13.05 USD
Based on its market price of 12.76 USD and our intrinsic valuation, Reviv3 Procare Co (RVIV) is overvalued by 20.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.48 - 13.05 | 10.20 | -20.0% |
| DCF (Growth 10y) | 12.85 - 20.58 | 15.77 | 23.6% |
| DCF (EBITDA 5y) | 17.20 - 20.81 | 18.93 | 48.3% |
| DCF (EBITDA 10y) | 22.53 - 29.86 | 25.91 | 103.1% |
| Fair Value | 0.39 - 0.39 | 0.39 | -96.98% |
| P/E | 5.28 - 7.82 | 6.55 | -48.7% |
| EV/EBITDA | 9.77 - 12.92 | 11.58 | -9.2% |
| EPV | 1.03 - 0.99 | 1.01 | -92.1% |
| DDM - Stable | 3.18 - 6.75 | 4.97 | -61.1% |
| DDM - Multi | 6.33 - 10.90 | 8.05 | -36.9% |
| Market Cap (mil) | 55.28 |
| Beta | 0.07 |
| Outstanding shares (mil) | 4.33 |
| Enterprise Value (mil) | 50.38 |
| Market risk premium | 5.00% |
| Cost of Equity | 7.86% |
| Cost of Debt | 4.46% |
| WACC | 7.84% |